Aplastic anemia secondary to dual cancer immunotherapies a physician nightmare: case report and literature review

BACKGROUND: Treatment with immune checkpoint inhibitors has revolutionized cancer treatment over the past several years. Despite their clinical benefits, a wide range of immune-mediated toxicities can be observed including hematological toxicities. Although, the majority can easily be managed, immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Younan, Romy G., Raad, Roy A., Sawan, Bassem Y., Said, Rabih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549247/
https://www.ncbi.nlm.nih.gov/pubmed/34702371
http://dx.doi.org/10.1186/s13223-021-00616-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8549247/
https://www.ncbi.nlm.nih.gov/pubmed/34702371
http://dx.doi.org/10.1186/s13223-021-00616-4

Ejemplares similares